Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

WASHINGTON - The U.S. Food and Drug Administration has cleared a formulation of the COVID-19 antibody drug made by Regeneron Pharmaceuticals Inc. that can be injected, rather than administered by IV ...

While administering monoclonal antibodies via intravenous infusion is standard practice to prevent severe hospitalization and death in outpatients with COVID-19, new research from UPMC shows giving ...

The Food and Drug Administration (FDA) has authorized Regeneron’s COVID-19 antibody drug for injections. Regeneron said in a statement on Friday that the agency updated the emergency use authorization ...

(Reuters) -Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen administered via the standard ...

RALEIGH, N.C. (WTVD) -- Katherine Wall and her whole family got COVID-19 in January before vaccines were readily available. She said she has an underlying autoimmune disease and got really sick. "I ...

June 4 (Reuters) - The U.S. health regulator authorized a lower dose of Regeneron Pharmaceutical’s COVID-19 antibody cocktail that can be given by injection, a move that could ease logistical ...

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency-use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients when ...

Antibody infusions a 'game-changer' in fight against Covid From left, Melissa Edmister, Jesse Arneson and Leah Scaramuzzo at Logan Health Medical Center on Nov. 9, 2021. (Matt Baldwin/Daily Inter Lake ...

Nov 12 (Reuters) - Britain's GSK (GSK.L), opens new tab and partner Vir (VIR.O), opens new tab said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a ...

U.S. health regulators have authorized newer, more convenient forms of a Covid-19 antibody drug made by Regeneron Pharmaceuticals Inc.REGN0.49%increase; green up pointing triangle that could make it ...